The immunoneuroendocrine axis in critical illness: Beneficial adaptation or neuroendocrine exhaustion?

Current Opinion in Critical Care

Volumn 10, Issue 6, 2004, Pages 461-467

  Beishuizen, Albertus ^a   Thijs, Lambertus G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adrenal insufficiency; Glucocorticoids; Hypothalamic pituitary adrenal axis; Neuroendocrinology; Prolonged illness; Sepsis

Indexed keywords

ANDROSTERONE DERIVATIVE; CORTICOSTEROID; CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; MACROPHAGE MIGRATION INHIBITION FACTOR; PRASTERONE SULFATE; TRANSCORTIN;

ADENOHYPOPHYSIS; ADRENAL INSUFFICIENCY; CORTICOTROPIN BLOOD LEVEL; CRITICAL ILLNESS; ENDOCRINE SYSTEM; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOPHYSIS FUNCTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; NEUROENDOCRINE DISEASE; NEUROENDOCRINE SYSTEM; REVIEW; SEPSIS; UPREGULATION;

EID: 10244246546     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccx.0000142748.40422.c8     Document Type: Review

References (75)

1. Blalock JE: A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev 1989, 69:1-32.
2. Besedovsky HO, Del Rey A: Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 1996, 17:64-102.
3. Van den Berghe G, de Zegher F, Bouillon R: Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998, 83:1827-1834.
4. Van den Berghe G: Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 2000, 143:1-13.
5. Van den Berghe G: Endocrinology in intensive care medicine: new insights and therapeutic consequences. Verh K Acad Geneeskd Belg 2002, 64:167-187.
6. Van den Berghe G, Wouters P, Weekers F, et al.: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
7. Annane D, Sebille V, Charpentier C, et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
8. Reichlin S: Neuroendocrine-immune interactions. N Engl J Med 1993, 329:1246-1253.
9. Munck A, Guyre PM, Holbrook NJ: Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 1984, 5:25-44.
10. Amsterdam A, Tajima K, Sasson R: Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem Pharmacol 2002, 64:843-850.
11. Imura H, Fukata J: Endocrine-paracrine interaction in communication between the immune and endocrine systems. Activation of the hypothalamic- pituitary-adrenal axis in inflammation. Eur J Endocrinol 1994, 130:32-37.
12. Beishuizen A, Vermes I, Haanen C: Endogenous mediators in sepsis and septic shock. Adv Clin Chem 1998, 33:55-131.
13. Ray D, Melmed S: Pituitary cytokine and growth factor expression and action. Endocr Rev 1997, 18:206-228.
14. Bernard C: Leçons sur les Phénomènes de la Vie Communs aux Animaux et aux Végétaux. Paris: Bailliere; 1878.
15. Cannon W: The emergency function of the adrenal medulla in pain and the major emotions. Am J Physiol 1914, 33:356-372.
16. Selye H: A syndrome produced by diverse nocuous agents. Nature 1936, 136:32.
17. McEwen BS: Protective and damaging effects of stress mediators. N Engl J Med 1998, 338:171-179.
18. Perdrizet GA: Hans Selye and beyond: responses to stress. Cell Stress Chaperones 1997, 2:214-219.
19. Vermes I, Beishuizen A, Hampsink RM, et al.: Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 1995, 80:1238-1242.
20. Vermes I, Beishuizen A: The hypothalamic-pituitary-adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab 2001, 15:495-511.
21. Beishuizen A, Thijs LG, Haanen C, et al.: Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab 2001, 86:2811-2816.
22. Reincke M, Allolio B, Wurth G, et al.: The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab 1993, 77:151-156.
23. Bornstein SR, Chrousos GP: Clinical review 104: adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab 1999, 84:1729-1736.
24. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, et al.: Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 1998, 19:101-143.
25. Ekman R, Servenius B, Castro MG, et al.: Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes. J Neuroimmunol 1993, 44:7-13.
26. Stephanou A, Jessop DS, Knight RA, et al.: Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes. Brain Behav Immun 1990, 4:67-73.
27. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995, 332:1351-1362.
28. Judd AM: Cytokine expression in the rat adrenal cortex. Horm Metab Res 1998, 30:404-410.
29. Marx C, Ehrhart-Bornstein M, Scherbaum WA, et al.: Regulation of adrenocortical function by cytokines relevance for immune-endocrine interaction. Horm Metab Res 1998, 30:416-420.
30. Hammond GL, Smith CL, Paterson NA, et al.: A role for corticosteroid-binding globulin in delivery of cortisol to activated neutrophils. J Clin Endocrinol Metab 1990, 71:34-39.
31. Beishuizen A, Thijs LG, Vermes I: Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 2001, 27:1584-1591.
32. Bladon PT, Rowlands TE, Whittaker JA, et al.: Serum cortisol binding capacity measured with concanavalin A-Sepharose in patients with a recent inflammatory response. Clin Chim Acta 1996, 253:9-20.
33. Pemberton AB, Stein PE, Pepys MB, et al.: Hormone binding globulins undergo serpin conformational change in inflammation. Nature 1988, 336:257-258.
34. Hammond GL, Smith CL, Underhill DA: Molecular studies of corticosteroid binding globulin structure, biosynthesis and function. J Steroid Biochem Mol Biol 1991, 40:755-762.
35. Hamrahian AH, Oseni TS, Arafah BM: Measurements of Serum Free Cortisol in Critically III Patients. N Engl J Med 2004, 350:1629-1638.
36. Bamberger CM, Schulte HM, Chrousos GP: Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 1996, 17:245-261.
37. Vottero A, Chrousos GP: Glucocorticoid Receptor beta View I. Trends Endocrinol Metab 1999, 10:333-338.
38. Molijn GJ, Koper JW, van Uffelen CJ, et al.: Temperature-induced downregulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock. Clin Endocrinol (Oxf) 1995, 43:197-203.
39. Molijn GJ, Spek JJ, van Uffelen JC, et al.: Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metab 1995, 80:1799-1803.
40. Perrot D, Bonneton A, Dechaud H, et al.: Hypercortisolism in septic shock is not suppressible by dexamethasone infusion. Crit Care Med 1993, 21:396-401.
41. Ebeling P, Koivisto VA: Physiological importance of dehydroepiandrosterone. Lancet 1994, 343:1479-1481.
42. Parker LN, Levin ER, Lifrak ET: Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985, 60:947-952.
43. Luppa P, Munker R, Nagel D, et al.: Serum androgens in intensive-care patients: correlations with clinical findings. Clin Endocrinol (Oxf) 1991, 34:305-310.
44. Van den Berghe G, de Zegher F, Wouters P, et al.: Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. Clin Endocrinol (Oxf) 1995, 43:457-463.
45. Beishuizen A, Thijs LG, Vermes I: Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? Crit Care 2002, 6:434-438.
46. Araneo BA, Shelby J, Li GZ, et al.: Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence. Arch Surg 1993, 128:318-325.
47. Schurr MJ, Fabian TC, Croce MA, et al.: Dehydroepiandrosterone, an endogenous immune modulator, after traumatic shock. Shock 1997, 7:55-59.
48. Findling JW, Waters VO, Raff H: The dissociation of renin and aldosterone during critical illness. J Clin Endocrinol Metab 1987, 64:592-595.
49. Zipser RD, Davenport MW, Martin KL, et al.: Hyperreninemic hypoaldosteronism in the critically ill: a new entity. J Clin Endocrinol Metab 1981, 53:867-873.
50. Bucala R: MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J 1996, 10:1607-1613.
51. Bernhagen J, Calandra T, Mitchell RA, et al.: MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993, 365:756-759.
52. Calandra T, Spiegel LA, Metz CN, et al.: Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of gram-positive bacteria. Proc Natl Acad Sci U S A 1998, 95:11383-11388.
53. Calandra T, Echtenacher B, Roy DL, et al.: Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000, 6:164-170.
54. Donnelly SC, Bucala R: Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. Mol Med Today 1997, 3:502-507.
55. Bozza M, Satoskar AR, Lin G, et al.: Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999, 189:341-346.
56. Calandra T, Bernhagen J, Metz CN, et al.: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995, 377:68-71.
57. Bacher M, Metz CN, Calandra T, et al.: An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 1996, 93:7849-7854.
58. Martin TR: MIF mediation of sepsis. Nat Med 2000, 6:140-141.
59. Kleemann R, Hausser A, Geiger G, et al.: Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000, 408:211-216.
60. Daun JM, Cannon JG: Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IkappaBalpha. Am J Physiol Regul Integr Comp Physiol 2000, 279:R1043-R1049.
61. Meduri GU, Tolley EA, Chrousos GP, et al.: Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002, 165:983-991.
62. Lai KN, Leung JC, Metz CN, et al.: Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J Pathol 2003, 199:496-508.
63. Calandra T, Froidevaux C, Martin C, et al.: Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis. J Infect Dis 2003, 187(suppl 2):S385-S390.
64. Lamberts SW, Bruining HA, de Jong FH: Corticosteroid therapy in severe illness. N Engl J Med 1997, 337:1285-1292.
65. Beishuizen A, Vermes I, Hylkema BS, et al.: Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet 1999, 353:1675-1676.
66. Annane D, Sebille V, Troche G, et al.: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000, 283:1038-1045.
67. Marik PE, Zaloga GP: Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002, 122:1784-1796.
68. Annane D, Raphael JC, Gajdos P: Are endogenous glucocorticoid levels adequate in septic shock? Intensive Care Med 1996, 22:711-712.
69. Matot I, Sprung CL: Corticosteroids in septic shock: resurrection of the last rites? Crit Care Med 1998, 26:627-630.
70. Streeten DH, Anderson GH Jr, Bonaventura MM: The potential for serious consequences from misinterpreting normal responses to the rapid adrenocorticotropin test. J Clin Endocrinol Metab 1996, 81:285-290.
71. Streeten DH: What test for hypothalamic-pituitary-adrenocortical insufficiency? Lancet 1999, 354:179-180.
72. Briegel J, Forst H, Haller M, et al.: Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999, 27:723-732.
73. Bollaert PE, Charpentier C, Levy B, et al.: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998, 26:645-650.
74. Cooper MS, Stewart PM: Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003, 348:727-734. This is a recent and useful review on adrenal failure in the critically ill.
75. Dorin RI, Qualls CR, Crapo LM: Diagnosis of adrenal insufficiency. Ann Intern Med 2003, 139:194-204.